Supplementary Figure 3 from Co-occurring EGFR P.e709x Mutation Mediates Primary Resistance to the Third-Generation EGFR-TKIs in EGFR P.g719x-Mutant Patients with Advanced NSCLC

openalex（2024）

引用 0|浏览1

暂无评分

摘要

Supplementary Figure 3. Genomic characteristics was found between patients receiving afatinib or the third-generation EGFR-TKIs.

查看译文

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要